Following the publication of this paper, it was drawn to the Editor's attention by a concerned reader that the agarose gel electrophoretic bands shown in Fig. 4A for PKC were strikingly similar to bands that had already appeared in another article written by different authors at different research institutes. Owing to the fact that the contentious data in the above article had already been published prior to its submission to , the Editor has decided that this paper should be retracted from the Journal. The authors were asked for an explanation to account for these concerns, but the Editorial Office did not receive a reply. The Editor apologizes to the readership for any inconvenience caused. [Oncology Reports 36: 165‑172, 2016; DOI: 10.3892/or.2016.4794].

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10777468PMC
http://dx.doi.org/10.3892/or.2023.8684DOI Listing

Publication Analysis

Top Keywords

[retracted] isoquercitrin
4
isoquercitrin inhibits
4
inhibits bladder
4
bladder cancer
4
cancer progression
4
progression regulating
4
regulating pi3k/akt
4
pi3k/akt pkc
4
pkc signaling
4
signaling pathways
4

Similar Publications

Following the publication of this paper, it was drawn to the Editor's attention by a concerned reader that the agarose gel electrophoretic bands shown in Fig. 4A for PKC were strikingly similar to bands that had already appeared in another article written by different authors at different research institutes. Owing to the fact that the contentious data in the above article had already been published prior to its submission to , the Editor has decided that this paper should be retracted from the Journal.

View Article and Find Full Text PDF

Background: A previously unstudied medicinal plant, (Berland.) I.M.

View Article and Find Full Text PDF

[Retracted] Isoquercitrin inhibits the progression of liver cancer and via the MAPK signalling pathway.

Oncol Rep

April 2023

Department of Hepatobiliary Surgery, Guilin Medical University, Affiliated Hospital, Guilin, Guangxi 541001, P.R. China.

Subsequently to the publication of the above article, a concerned reader drew to our attention that the data panel shown in Fig. 7A for the 400 μM isoquercitrin experiment had previously appeared in Fig. 4A in another article published in the journal [Tang B, Li Y, Yuan S, Tomlinson S and He S: Upregulation of the δ opioid receptor in liver cancer promotes liver cancer progression both in vitro and in vivo.

View Article and Find Full Text PDF

Subsequent to the publication of the above article, a concerned reader drew to our attention that the flow cytometric plots shown in Fig. 2 had previously appeared in another article published in the journal Oncology Reports [Huang G, Tang B, Tang K, Dong X, Deng J, Liao L, Liao Z, Yang H and He S: Isoquercitrin inhibits the progression of liver cancer and via the MAPK signalling pathway. Oncol Rep 31: 2377‑2384, 2014], suggesting that data purportedly showing results obtained under different experimental conditions had been derived from the same original source.

View Article and Find Full Text PDF

Bladder cancer is the most common malignancy of the urinary system and is also one of the 10 most common cancers of the human body. Currently, clinical treatment of bladder cancer mainly utilizes partial or total cystectomy, supplemented by conventional chemotherapy. However, such treatment has not fully improved the prognosis of patients and is associated with various side effects.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!